CXCR3 Chemokines in Type I Diabetes
CXCR3 Chemokines in Type I Diabetes
批准号:
7856786
负责人:
Matthias G. Von Herrath
金额:
$1.66万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-05 至 2009-11-30
关键词:
Adverse effectsAffectAntibodiesAutoimmune DiabetesBeta CellCXC chemokine receptor 3CXCL10 geneCXCR3 geneCellsDataDiagnosisEventExperimental ModelsFoundationsGoalsHumanImmuneImmune systemInbred NOD MiceIndividualInsulinInsulin-Dependent Diabetes MellitusInterferonsIslets of LangerhansIslets of Langerhans TransplantationLymphocyteMusPathogenesisPopulationProteinsResearch PersonnelRoleT-LymphocyteTherapeuticTimeTransplantationVirus Diseasesbasechemokinediabeticin vivoinsightisletislet allograftmigrationnovelpreventprogramsresearch studyresponsetrafficking
中文摘要
描述(由申请人提供):我们的目标是从机制上了解IP-10(10 kDa干扰素诱导蛋白,CXCL 10)及其受体CXCR 3在1型糖尿病(T1 D)和胰岛移植排斥反应发病机制中的作用。基于这一认识,我们希望分析IP-10阻断在诱导和自发性自身免疫性糖尿病(RIP-LCMV和NOD小鼠)和胰岛移植的实验模型中的治疗潜力。我们相信,这种集中的分析将揭示新的干预途径,以防止破坏胰岛素产生β细胞和恢复对胰岛的长期耐受性。令人鼓舞的初步数据表明,在全身IP-10阻断后,RIPLCMV小鼠中病毒诱导的T1 D得到了显著改善。重要的是,这种临床有益效果是在没有任何可检测到的副作用的情况下获得的。一个有趣的观察结果是IP-10阻断似乎主要影响侵袭性T淋巴细胞迁移/吸引到胰岛中,而不是免疫应答的总体降低。因此,我们假设IP-10是一个独特的免疫学靶点,因为它的阻断将选择性地影响淋巴细胞在胰岛中的积聚。事实上,体内施用针对其他趋化因子的抗体没有类似的深刻影响。
目的1:IP-10在T1 D发病机制中的重要性-治疗性阻断和机制
分析。
目的2:IP-10在胰岛移植排斥反应中的重要性-治疗性阻断和机制分析。
英文摘要
DESCRIPTION (provided by applicant): Our goal is to mechanistically understand the role of IP-10 (interferon-induced protein of 10kDa, CXCL10) and its receptor CXCR3 in the pathogenesis of type 1 diabetes (T1D) and islet allograft rejection. Based on this insight we wish to analyze the therapeutic potential of IP-10 blockade in experimental models of induced and spontaneous autoimmune diabetes (RIP-LCMV and NOD mice) and islet transplantation. We believe that this focused analysis will unravel novel interventive avenues to prevent destruction of insulin producing beta-cells and restore long-term tolerance to islets. Encouraging preliminary data demonstrate a profound amelioration of virally induced T1D in RIPLCMV mice after systemic IP-10 blockade. Importantly, this clinically beneficial effect was obtained without any detectable side effects. An intriguing observation is that IP-10 blockade appears to predominantly affect migration/attraction of aggressive T lymphocytes into the islets rather than overall reduction of immune responsiveness. Thus, we hypothesize that IP-10 is a unique immunological target in that its blockade will selectively affect lymphocyte accumulation in the islets of Langerhans. Indeed, in vivo administration of antibodies against other chemokines did not have a similarly profound effect.
Aim 1: Importance of IP-10 in the pathogenesis of T1D - therapeutic blockade and mechanistic
analyses.
Aim 2: Importance of IP-10 during islet allograft rejection - therapeutic blockade and mechanistic analyses.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2337/db12-1370
发表时间:
2013-07
期刊:
Diabetes
影响因子:
7.7
作者:
[Coppieters KT, Amirian N, Pagni PP, Baca Jones C, Wiberg A, Lasch S, Hintermann E, Christen U, von Herrath MG]
通讯作者:
von Herrath MG
Viral infection--a cure for type 1 diabetes?
病毒感染——1型糖尿病的治疗方法?
DOI:
10.2174/092986707781368397
发表时间:
2007
期刊:
Current medicinal chemistry
影响因子:
4.1
作者:
[Hintermann,Edith, Christen,Urs]
通讯作者:
Christen,Urs
Treg stability in viral infection and autoimmunity
-
批准号:8495227
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2013
-
负责人:Matthias G. Von Herrath
-
依托单位:
Treg stability in viral infection and autoimmunity
-
批准号:8377922
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2012
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8655830
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8261913
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8195256
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
-
批准号:9238399
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8451478
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8828063
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
-
批准号:10061526
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Treg stability in viral infection and autoimmunity
-
批准号:8006796
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2010
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7919813
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2009
-
负责人:Matthias G. Von Herrath
-
依托单位:
Viruses and Autoimmunity POI
-
批准号:7923514
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2009
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7667337
-
项目类别:
-
资助金额:$41.72万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7487519
-
项目类别:
-
资助金额:$41.72万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7313053
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7914240
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
-
批准号:7469963
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
-
批准号:7289765
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Assessment of cytokines in human islets from patients with diabetes
-
批准号:8501368
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Assessment of cytokines in human islets from patients with diabetes
-
批准号:8373378
-
项目类别:
-
资助金额:$44.77万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
海外基金